Trademark Filing
Reven Pharmaceuticals, Inc.
Trademark Registered: 2019-02-26
Trademark Application Details
STATEMENT OF USE - TO EXAMINER
| Serial Number | 86628038 |
| Registration Number | 5686421 |
| Mark Drawing Code | 2000: Illustration: Drawing or design without any word(s)/letter(s)/ number(s) |
| Attorney Name | Michael F. Snyder |
| Attorney Docket Number | RPI2-TM003 |
| Law Office Assigned | M80 |
| Employee Name | JACKSON, WILLIAM D |
Timeline
| 2015-05-13 | Application Filed |
| 2015-10-27 | Published for Opposition |
| 2018-12-21 | Date of First Use |
| 2019-01-07 | Location: TMO LAW OFFICE 117 |
| 2019-01-07 | Status: Live/Pending |
| 2019-01-07 | Transaction Date |
| 2019-02-26 | Trademark Registered |
Trademark Applicants & Owners
| Owner: |  Reven Pharmaceuticals, Inc. |
| Address | 600 Corporate Circle #C Golden FL 80401 |
| Legal Entity Type | Corporation |
| Legal Entity State | FL |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Design Search Codes
| 260105 | Circles made of broken or dotted lines |
| 260111 | Circles comprised of animals; Circles comprised of geometric figures; Circles comprised of humans; Circles comprised of letters or numerals; Circles comprised of plants; Circles comprised of punctuation; Letters, numerals, punctuation, geometric figures, objects, humans, plants or animals comprising a circle |
| 260128 | Circles with irregular circumferences; Miscellaneous circular designs with an irregular circumference |
Attorney of Record
Good, Services, and Codes
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0421 | Pharmaceutical research and development in the fields of cardiovascular disease, vascular therapy, skin conditions, diabetic conditions, cancer, infectious disease, sports enhancement, nerve system disease, brain disease and mitochondrial disease; Pharmaceutical services, namely, the development of pharmaceuticals for the treatment of cardiovascular disease, vascular therapy, skin conditions, diabetic conditions, cancer, infectious disease, sports enhancement, nerve system disease, brain disease and mitochondrial disease |
| CC0000 | Color is not claimed as a feature of the mark. |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2015-05-16 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2015-05-20 | 2 NWOS I:Incoming Correspondence |
| NOTICE OF DESIGN SEARCH CODE E-MAILED | 2015-05-21 | 3 MDSC E:E-Mail |
| ASSIGNED TO EXAMINER | 2015-08-19 | 4 DOCK D:Assigned to Examiner |
| EXAMINERS AMENDMENT -WRITTEN | 2015-08-21 | 5 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2015-08-21 | 6 GNEA F:First Action |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2015-08-21 | 7 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2015-08-21 | 8 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2015-08-21 | 9 CNSA P: |
| ASSIGNED TO LIE | 2015-09-17 | 10 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2015-09-18 | 11 PREV O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2015-10-07 | 12 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2015-10-27 | 13 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2015-10-27 | 14 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2015-12-22 | 15 NOAM E:E-Mail |
| TEAS EXTENSION RECEIVED | 2016-06-22 | 16 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2016-06-22 | 17 EXT1 S: |
| EXTENSION 1 GRANTED | 2016-06-22 | 18 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2016-06-24 | 19 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2016-12-22 | 20 EEXT I:Incoming Correspondence |
| EXTENSION 2 FILED | 2016-12-22 | 21 EXT2 S: |
| EXTENSION 2 GRANTED | 2016-12-22 | 22 EX2G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2016-12-24 | 23 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2017-06-22 | 24 EEXT I:Incoming Correspondence |
| EXTENSION 3 FILED | 2017-06-22 | 25 EXT3 S: |
| EXTENSION 3 GRANTED | 2017-06-22 | 26 EX3G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2017-06-24 | 27 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2017-12-21 | 28 EEXT I:Incoming Correspondence |
| EXTENSION 4 FILED | 2017-12-21 | 29 EXT4 S: |
| EXTENSION 4 GRANTED | 2017-12-21 | 30 EX4G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2017-12-23 | 31 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2018-06-22 | 32 EEXT I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2018-06-25 | 33 AITU A:Allowance for Publication |
| EXTENSION 5 FILED | 2018-06-22 | 34 EXT5 S: |
| EXTENSION 5 GRANTED | 2018-06-25 | 35 EX5G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2018-06-26 | 36 EXRA E:E-Mail |
| TEAS STATEMENT OF USE RECEIVED | 2018-12-26 | 37 EISU I:Incoming Correspondence |
| USE AMENDMENT FILED | 2018-12-24 | 38 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2019-01-07 | 39 SUPC I:Incoming Correspondence |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2019-01-23 | 40 CNPR P: |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2019-01-24 | 41 SUNA E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2019-02-26 | 42 R.PR A:Allowance for Publication |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2024-02-26 | 43 REM1 E:E-Mail |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 